For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Salutar, Inc.

Calculating rank

USPTO Granted Patents = 33

Forward Citations = 841

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Steven C Quay (24 out of 94 patents)

Scott M Rocklage (24 out of 35 patents)

William P Cacheris (4 out of 4 patents)

4. Alan D Watson (4 out of 14 patents)

5. Gene Curtis Jamieson (3 out of 20 patents)

6. Warren K Miller (3 out of 3 patents)

7. Dilip M Worah (3 out of 3 patents)

8. Karl F Kraft (2 out of 2 patents)

9. David B Love (2 out of 3 patents)

10. Richard J Himmelsbach (2 out of 4 patents)

11. William C Dow (2 out of 6 patents)

12. John Kucharczyk (1 out of 3 patents)

13. Michael E Moseley (1 out of 3 patents)

14. Stephen C Quay (1 out of 1 patent)

15. Paul F Sieving (1 out of 3 patents)

Core Competencies:

Polychelants

Manganese (II)

Contrast Agents

Magnetic Resonance Imaging

Chelating Compounds

Dipyridoxyl Phosphate

NMR Imaging

Amyloidosis

Alzheimer's Disease

DTPA

Paramagnetic

Intermediates

33 patents: Sort by Forward Citations

1. 6274713 - Polychelants (2001-08-14),

2. 5914095 - Polychelants containg amide bonds (1999-06-22),

3. 5679810 - Linear oligomeric polychelant compounds (1997-10-21),

4. 5281704 - Polychelant compounds (1994-01-25),

5. 5223243 - Dipyridoxyl phosphate chelating compound intermediates useful as NMRI (1993-06-29),

6. 5219553 - Composition of a n-carboxymethylated tetraazacyclododecane chelating (1993-06-15),

7. 5190744 - Methods for detecting blood perfusion variations by magnetic resonance (1993-03-02),

8. 5155224 - Manganese (II) chelates (1992-10-13),

9. 5130437 - N,N'-bis-(pyridoxal)ethylenediamine-N,N'-diacetic acid derivatives (1992-07-14),

10. 5130431 - Dipyriodoxyl phosphate chelating compound intermediates (1992-07-14),

11. 5091169 - Dipyridoxyl phosphate NMRI contrast agent compositions (1992-02-25),

12. 5089644 - Preparation of oxamine complexes (1992-02-18),

13. 5087440 - Heterocyclic derivatives of DTPA used for magnetic resonance imaging (1992-02-11),

14. 5087439 - Paramagnetic metal-diethylenetriamine-pentaacetic acid partial amide (1992-02-11),

15. 5039512 - NMR imaging with paramagnetic polyvalent metal salts of (1991-08-13),

Company Overview

Salutar, Inc. is a technology-driven organization based in Sunnyvale, California, specializing in the development and manufacturing of advanced medical devices and innovative healthcare solutions. The company focuses on enhancing patient care through cutting-edge technologies, particularly in the fields of drug delivery systems and therapeutic devices. Salutar's commitment to research and development positions it at the forefront of medical innovation, aiming to improve health outcomes and streamline healthcare processes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

33 Patents

#135 in Sunnyvale, CA

#2,462 in California

#10,309 in US

#20,162 in the World

Sunnyvale, CA, United States of America

Salutar, Inc.

Forward Citations = 841

16 inventors:

Steven C Quay (24 out of 94 patents)

Scott M Rocklage (24 out of 35 patents)

William P Cacheris (4 out of 4 patents)

4. Alan D Watson (4 out of 14 patents)

5. Gene Curtis Jamieson (3 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Salutar, Inc.. Retrieved from https://idiyas.com/company/salutar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…